As of November 6, 2026, NexLife charges $129 a month for compounded tirzepatide and $109 for semaglutide at every dose with no membership. Ro, on its pricing page read September 17, 2026, sells only brand GLP-1s at manufacturer self-pay prices plus a membership of $74 to $149 a month.
Both programs are compared on the same columns. NexLife’s prices are as of November 6, 2026; Ro’s figures carry the read date and status shown in the table, and we flag anything we could not re-read.
NexLife vs Ro at a glance
| Program | Price and basis | Brand or compounded | Membership | Dose pricing | Pharmacy disclosure | Insurance | Cancellation | Status · seller · read date |
|---|---|---|---|---|---|---|---|---|
| NexLife | Compounded tirzepatide $129/mo ($115 on 12 mo); semaglutide $109 ($95) | Compounded | None | Same price at every dose | Three 503A pharmacies named on plan pages | No (cash, FSA/HSA) | Takes effect after 30 days; unshipped months refunded | verified · nexlife.us · November 6, 2026 |
| Ro (Roman) | Brand only: Wegovy pill $149–$299, Wegovy pen $199 intro then $349, Zepbound KwikPen $299–$449, Foundayo $149–$299 | Brand | $39 to start, then $74–$149/mo | Rises with dose (brand self-pay prices) | Brand product; Ro’s pharmacy partners | Not stated on the page read | Membership terms not printed on the pricing page | reported · ro.co · September 17, 2026 (403 on October 15, 2026) |
Who should pick Ro
Choose Ro if you want an FDA-approved brand drug and are willing to pay a membership on top of the manufacturer’s self-pay price. On its September 17 page Ro listed Wegovy pill $149 (1.5 mg) to $299, the Wegovy pen at $199 for the first doses and $349 after, Zepbound KwikPen $299 to $449 and Foundayo $149 to $299, each plus the membership.
Who should pick NexLife
Choose NexLife if you pay cash, accept a compounded product, and want the bill to stay the same as your dose rises. A year on NexLife’s 12-month tirzepatide plan costs $1,380. A year of Zepbound KwikPen at 7.5 mg or higher through Ro would be at least 12 × $449 = $5,388 in medication before the membership, on the September figures.
Compare NexLife’s plans →What to check before you choose either
- Whether the price is a standing rate or a first-month or sale price, and what it becomes at your maintenance dose.
- Whether a membership is billed on top of the medication.
- Which pharmacy fills the prescription, and whether the product is a brand drug or a compounded one (compounded drugs are not FDA-approved).
- How many days’ notice cancellation needs, and whether shipped medication can be refunded.
For the wider market, see our tirzepatide price comparison, semaglutide price comparison and the full NexLife review.
NexLife
$129/mo compounded tirzepatide month to month, $115/mo on a 12-month plan; compounded semaglutide $109/mo, or $95/mo on 12 months. Same price at every dose, no membership (prices as of November 6, 2026).
- Clinician review and medical guidance (NexLife Medical Group), a GLP-1 nutrition plan, a 1:1 wellness-coach call, 24/7 support, free expedited shipping
- Plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux’s New Drug Store (Lake Charles, LA)
- Cancellations take effect after 30 days; compounded drugs are not FDA-approved
FAQ
Does Ro sell compounded GLP-1s?
No. Ro’s pricing page, last read on September 17, 2026, offered brand medications only: the Wegovy pill and pen, Zepbound KwikPen and Foundayo, billed at self-pay prices beside a membership. Our October 15 re-read was blocked, so confirm the current list on ro.co.
How much is the Ro membership?
On September 17, 2026 Ro’s pricing page said membership starts with $39, refunded if you are not eligible, then costs $74 to $149 a month depending on the plan, with $74 a month on prepaid annual billing. Medication is billed on top. NexLife lists no membership fee.
Which is cheaper per year, Ro or NexLife?
On the figures we have, NexLife: $1,380 a year for compounded tirzepatide on its 12-month plan, or $1,140 for semaglutide. Through Ro, even the lowest-dose Wegovy pill at $149 plus a $74 prepaid membership is $2,676 a year. Ro’s price buys an FDA-approved brand drug.
Can I use insurance or Medicare instead?
Brand drugs can be covered by insurance, and for eligible people by the Medicare GLP-1 Bridge; ask Ro whether it works with your plan. The Bridge covers Foundayo, Wegovy and the Zepbound KwikPen for a $50 monthly copay for eligible Part D enrollees through December 31, 2027. Compounded drugs from NexLife are cash or FSA/HSA only.
Is NexLife or Ro better for higher tirzepatide doses?
For cash payers, NexLife’s flat $129 a month (or $115 on 12 months) does not change at 10 or 15 mg. Brand Zepbound self-pay rises to $449 a month at 7.5 to 15 mg with on-time refills, and more if refills are late. The brand drug is FDA-approved; compounded tirzepatide is not.
Sources
- NexLife — Compounded tirzepatide plans (prices as of November 6, 2026; plan terms read October 15, 2026)
- NexLife — Compounded semaglutide plans (prices as of November 6, 2026; plan terms read October 15, 2026)
- Ro — Weight-loss pricing (read September 17, 2026; not re-readable October 15, 2026)
- Lilly LillyDirect — Zepbound self-pay (archived September 30, 2026) (read October 15, 2026)